港股異動丨華虹半導體(1347.HK)漲近6%收復昨日失地 12寸產能利用率不斷上升
格隆匯10月6日丨華虹半導體(1347.HK)漲近6%收復昨日失地,報29.4港元,總市值381億港元。中金公司發佈最新研報稱,華虹半導體位於無錫的12寸廠產能利用率不斷上升;同時,由於需求好於預期,公司考慮對無錫廠進行二期擴建。中金看好無錫產能爬坡,維持跑贏行業評級和目標價31港元(對應2.3倍2020年P/B)。出貨合規是華虹日常經營的重中之重。華虹強調,公司在日常運營中注重遵守美國法規。華虹是獲得美國“經驗證最終用户”(VEU)認證的兩家中國晶圓代工企業之一。該認證是一項通用授權,允許美國設備供應商將指定的物品運送到華虹,而免於申請獨立許可。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.